Pavmed (NSDQ:PAVM) has registered for a nearly $90 million offering, saying it plans to float the rights to buy up to 14.6 million units. The New York City-based company said it would issue a single unit for each share of common stock. Each unit is slated to include one common share and a six-year Series Z warrant worth […]
Funding Roundup
Pavmed sets terms for warrants offering
Pavmed (NSDQ:PAVM) said today that it set the terms for a forthcoming rights offering, saying it plans to issue a single unit for each share of common stock. Each unit will include one common share and a six-year Series Z warrant worth $2.25 per share, redeemable at $3 each, the New York City-based company said. Last […]
BioAdvance drops $3.2m on device, drug bets
Early-stage life science fund BioAdvance announced that it has added an array of new companies to its portfolio, investing nearly $3.2 million into companies from the mid-Atlantic region of the U.S. Two of the firm’s largest investments went to Opsidio, a Bryn Mawr, Penn.-based company developing monoclonal antibodies to treat fibrotic diseases, and New York-based Pillo Health, […]
Siemens Healthineers to cut costs by $290m ahead of IPO
Siemens (NYSE:SI) said today that it plans to shave more that $290 million from the cost of running its Healthineers business, ahead of a pending initial public offering that could fetch nearly $50 billion. Late last year, the German industrial conglomerate said it plans to list 15% to 25% of the its largest and most profitable business on […]
Hologic launches $1B debt offering
Hologic (NSDQ:HOLX) plans to launch a $1 billion private offering made up of 4.375% senior notes due 2025 and new senior notes due 2028. The company reported that it plans to use its available cash, the offering’s proceeds and funds from a revolving credit facility to redeem $1 billion of outstanding 5.25% senior notes due in […]
Stealthy Vicarious Surgical adds nearly $13m
Stealthy Vicarious Surgical reported raising nearly $13 million for the virtual reality software it’s developing for robot-assisted surgeries. Cambridge, Mass.-based Vicarious reported the equity offering, which involved two unnamed investors and began Jan. 4, in a regulatory filing last week. Details about Vicarious are scarce. The company’s 1-page website consists of a logo and email address; according to Khosla Ventures, the company “integrates […]
Aprinoia raises $11m for Alzheimer’s imaging, therapy programs
Aprinoia Therapeutics said today that it has raised $11.1 million in a Series B round, led by KTB Network and DCI Partners. The Taiwan-based biotech plans to use its new funds to advance the preclinical and clinical development of its tau PET imaging tracer and therapy programs for people with Alzheimer’s disease. Get the full story […]
Strapped for cash, Lombard Medical defaults on loan
Strapped for cash, Lombard Medical Technologies (NSDQ:EVAR) said last week that it received a default notice from one of its lenders. The Didcot, U.K.-based stent graft maker said Oxford Finance sent the default letter Jan. 12, four days after meeting with Lombard to discuss its finances. To make matters worse, Lombard said it doesn’t have enough […]
EndoStim adds $12m for neurostim GERD device
EndoStim last week reported raising more than $12 million for its neurostimulation device for treating gastroesophageal reflux disease. The Dallas-based company hopes to bring in a total of $25 million in the round, which follows a $25 million Series D financing in May 2016. The most recent equity and options funding involved 20 unnamed investors, according to a […]
Tandem Diabetes registers $40m offering
Tandem Diabetes Care (NSDQ:TNDM) has registered for a $40 million offering of its common stock, according to an SEC filing posted today. Shareholders for the San Deigo, Calif.-based company approved a proposal last year to effect a 1-for-10 reverse stock split that they believed would help make Tandem’s stock more attractive to institutional investors. Get the full story at our […]
Stimwave raises $50m for consumer launch of chronic pain neuromod device
Stimwave said this week that it raised more than $50 million from a consortium of unnamed investors for the consumer launch of its Freedom neuromodulation device for treating chronic pain. Pompano Beach, Fla.-based Stimwave said the Freedom stimulator is the sole FDA-approved wireless, micro-sized device cleared for treating neuropathic pain. The device uses a tiny injectable microchip […]